scholarly journals Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial

2000 ◽  
Vol 11 (4) ◽  
pp. 435-440 ◽  
Author(s):  
C. Manegold ◽  
U. Gatzemeier ◽  
J. von Pawel ◽  
R. Pirker ◽  
R. Malayeri ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Multicenter Phase ◽  
Pemetrexed Disodium

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

Lung Cancer ◽  
1998 ◽  
Vol 21 ◽  
pp. S33 ◽  
Author(s):  
V Georgoulias ◽  
Ch Kourousis ◽  
N Androulakis ◽  
S Kakolyris ◽  
MA Dimopoulos ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Multicenter Phase

scholarly journals P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial

2007 ◽  
Vol 2 (8) ◽  
pp. S824
Author(s):  
Andriani G. Charpidou ◽  
Nikolaos Katirtzoglou ◽  
Ioannis Gkiozos ◽  
Eleni Karapanagiotou ◽  
Anna Rigopoulou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Extensive Disease

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

2012 ◽  
Vol 13 (2) ◽  
pp. 129-135 ◽  
Author(s):  
Athanasios G. Pallis ◽  
Alexandra Voutsina ◽  
Nikolaos Kentepozidis ◽  
Stylianos Giassas ◽  
Pavlos Papakotoulas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung

scholarly journals Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer

2011 ◽  
Vol 6 (4) ◽  
pp. 786-789 ◽  
Author(s):  
Martin J. Edelman ◽  
Gregory Otterson ◽  
Joseph Leach ◽  
Thomas Malpass ◽  
Ravi Salgia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Motexafin Gadolinium ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document